Narsoplimab (OMS721)

narsoplimab · Omeros Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Narsoplimab (OMS721), covering 2024-08-28 to 2024-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies [Phase 2]